DOI: 10.25881/20728255_2026_21_4_S1_39

Authors

Petrachkov D.V., Altemirova Kh.Kh., Zenkin N.S., Pavlov V.G., Filippov V.M., Khanova A.N., Chizhonkova E.A.

M.M. Krasnov Research Institute of Eye Diseases, Moscow

Abstract

Background. Intraoperative retinal endolaser photocoagulation is an integral part of vitreoretinal surgery for complicated proliferative diabetic retinopathy; however, its optimal extent and localisation have not been defined, and their relationship with haemorrhagic, neovascular and macular complications remains insufficiently studied.

Aim. To evaluate the effect of the extent of intraoperative endolaser photocoagulation on the incidence of complications of vitreoretinal surgery for complicated proliferative diabetic retinopathy.

Material and methods. A prospective randomised study included 264 patients (264 eyes) who underwent vitrectomy with bimanual membrane peeling. In group 1 (98 eyes) no photocoagulation was performed; in group 2 (66 eyes) panretinal photocoagulation was applied in four quadrants of the near and mid periphery (1000–1500 burns); in group 3 (100 eyes) peripheral photocoagulation from the equator to the ora serrata (600–800 burns) was performed. Central retinal thickness and the incidence of macular oedema, vitreous haemorrhage, rubeosis iridis and neovascular glaucoma were assessed at 1 and 12 months.

Results. At 1 month the groups did not differ. At 12 months, vitreous haemorrhage with spontaneous resorption occurred in 37.89, 44.61 and 17.52% of eyes (p<0.001), rubeosis iridis and/or neovascular glaucoma in 24.21, 7.69 and 4.12% (p<0.001), and macular oedema in 47.36, 56.92 and 35.05% (p = 0.020) in groups 1, 2 and 3, respectively. The absence of photocoagulation was directly associated with vitreous haemorrhage with spontaneous resorption (p = 0.002) and anterior segment neovascular complications (p<0.001); no association between the extent of photocoagulation and central retinal thickness was found.

Conclusion. Omission of intraoperative photocoagulation is a risk factor for late haemorrhagic and neovascular complications, whereas peripheral photocoagulation is associated with the lowest incidence of complications, including macular oedema. The extent of intraoperative photocoagulation can be regarded as a prognostic criterion within a system of differentiated surgical treatment of diabetic angioretinoneuropathy.

Keywords: diabetic angioretinoneuropathy, proliferative diabetic retinopathy, vitreoretinal surgery, retinal endolaser photocoagulation, vitreous haemorrhage, rubeosis iridis, neovascular glaucoma, diabetic macular oedema, prognostic criteria.

References

1. Flaxman SR, Bourne RRA, Resnikoff S, et al. Vision Loss Expert Group of the Global Burden of Disease Study. Global causes of blindness and distance vision impairment 1990-2020: a systematic review and meta-analysis. Lancet Glob Health. 2017; 5(12): e1221-e1234. doi: 10.1016/ S2214-109X(17)30393-5.

2. Bikbov MM, Fayzrakhmanov RR, Kazakbaeva GM, et al. Prevalence, awareness and control of diabetes in Russia: The Ural Eye and Medical Study on adults aged 40+ years. PLoS One. 2019; 14(4): e0215636. doi: 10.1371/ journal.pone.0215636.

3. Diabetes mellitus: diabetic retinopathy, diabetic macular edema. Clinical guidelines. 2023. https://cr.minzdrav.gov.ru/recomend/115_2. (In Russ.)

4. Petrachkov DV, Filippov VM, Alkharki L. Comparative analysis of the diabetic retinopathy surgical treatment results in patients with various types of diabetes mellitus. Ophthalmology. Eastern Europe. 2022; 12(4): 435-447. (In Russ.) doi: 10.34883/PI.2022.12.4.013.

5. Yau GL, Silva PS, Arrigg PG, Sun JK. Postoperative Complications of Pars Plana Vitrectomy for Diabetic Retinal Disease. Semin Ophthalmol. 2018; 33(1): 126-133. doi: 10.1080/08820538.2017.1353832.

6. Shishkin MM, Safarli NN, Kasatikova EV, Antonyuk SV. Sparing vitreoretinal surgery for advanced proliferative diabetic retinopathy: justification, technique, long-term results. Bulletin of Pirogov National Medical & Surgical Center. 2009; 4(2): 23-28. (In Russ.)

7. Shishkin MM, Yuldasheva NM. Intravitreal injection of angiogenesis inhibitors as a stage of sparing vitreoretinal surgery for proliferative diabetic retinopathy. Bulletin of Pirogov National Medical & Surgical Center. 2011; 6(1): 77-81. (In Russ.)

8. Petrachkov DV, Budzinskaya MV, Matyushchenko AG, Sidamonidze AL, Filippov VM. Viscodissection with staining of epiretinal membranes in surgery of proliferative diabetic retinopathy. Vestn Oftalmol. 2021; 137(4): 18-23. (In Russ.) doi: 10.17116/oftalma202113704118.

9. Petrachkov DV, Filippov VM. Influence of Intraoperative Retinal Laser Photocoagulation Area and Localisation on the Complications Frequency of Surgical Treatment for Diabetic Retinopathy. Ophthalmology in Russia. 2025; 22(1): 54-62. (In Russ.) doi: 10.18008/1816-5095-2025-1-54-62.

10. Nisic F, Jovanovic N, Mavija M, Alimanovic-Halilovic E, Nisic A, Lepara O, Cemerlic A. Vitreous concentrations of vascular endothelial growth factor as a potential biomarker for postoperative complications following pars plana vitrectomy. Arch Med Sci. 2019; 15(2): 449-456. doi: 10.5114/ aoms.2018.73208.

11. Pei M, Zhao X, Wan G. A systematic review and meta-analysis of clinical outcomes of small gauge vitrectomy with or without intravitreal antivascular endothelial growth factor agents pretreatment for proliferative diabetic retinopathy. Ophthalmic Res. 2023. doi: 10.1159/000530231.

12. Patel V, Rohowetz LJ, Pakravan P, et al. Outcomes of Pars Plana Vitrectomy with Panretinal Photocoagulation for Treatment of Proliferative Diabetic Retinopathy Without Retinal Detachment: A Seven-Year Retrospective Study. Clin Ophthalmol. 2023; 17: 471-478. doi: 10.2147/OPTH.S400474.

13. Tan Y, Fukutomi A, Sun MT, et al. Anti-VEGF crunch syndrome in proliferative diabetic retinopathy: A review. Surv Ophthalmol. 2021; 66(6): 926-932. doi: 10.1016/j.survophthal.2021.03.001.

14. Petrachkov DV, Baryshev KV, Filippov VM. Analysis of hemorrhagic complications in surgery for proliferative diabetic retinopathy. Modern Technologies in Ophthalmology. 2022; 1(41): 108-113. (In Russ.) doi: 10.25276/2312-4911-2022-1-108-113.

15. Shimura M, Yasuda K, Nakazawa T, et al. Panretinal photocoagulation induces pro-inflammatory cytokines and macular thickening in high-risk proliferative diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol. 2009; 247(12): 1617-1624. doi: 10.1007/s00417-009-1147-x.

16. Shroff CM, Gupta C, Shroff D, et al. Bimanual microincision vitreous surgery for severe proliferative diabetic retinopathy: outcome in more than 300 eyes. Retina. 2018; 38 S1: S134-S145. doi: 10.1097/IAE.0000000000002093.

17. Gershoni A, Barayev E, Jbara D, et al. Postoperative complications of combined phacoemulsification and pars plana vitrectomy in diabetic retinopathy patients. Front Med (Lausanne). 2022; 9: 978346. doi: 10.3389/fmed.2022.978346.

18. Petrachkov DV, Baryshev KV, Arzhukhanov DD. Influence of intraoperative panretinal laser coagulation of the retina on the morphometric parameters of the macular area in patients with diabetic retinopathy in the early stages of follow-up. Saratov Journal of Medical Scientific Research. 2021; 17(2): 356-361. (In Russ.)

19. Damian I, Nicoară SD. Visual outcomes and prognostic factors following 23G vitrectomy for vitreous hemorrhage in eyes with proliferative diabetic retinopathy. Arq Bras Oftalmol. 2023; 86(2): 105-112. doi: 10.5935/ 0004-2749.20230037.

20. Sun D, Lin Y, Zeng R, et al. The incidence and risk factors of neovascular glaucoma secondary to proliferative diabetic retinopathy after vitrectomy. Eur J Ophthalmol. 2021; 31(6): 3057-3067. doi: 10.1177/1120672120980686.

For citation

Petrachkov D.V., Altemirova Kh.Kh., Zenkin N.S., Pavlov V.G., Filippov V.M., Khanova A.N., Chizhonkova E.A. Extent of intraoperative retinal endolaser photocoagulation as a prognostic criterion for complications of vitreoretinal surgery in diabetic angioretinoneuropathy. Bulletin of Pirogov National Medical & Surgical Center. 2026;21(4,supplement):39-44. (In Russ.) https://doi.org/10.25881/20728255_2026_21_4_S1_39